Kari Grønås

Kari Grønås is currently Chairman at Norwegian Cancer Society and Lungekreftforeningen.
Ms. Grønås is Director at Oncoinvent ASA since 2024, Independent Director at Spago Nanomedical AB since 2018, Managing Director & Director at K & K AS since 2012, and Director at Arxx Therapeutics AS.
Former roles include Chairman at Norwegian Pharmaceutical Society, Director at Oncopeptides AB, Lytix Biopharma AS, SoftOx.
Solutions AS, Ultimovacs ASA, and Oncoinvent ASA (Old).
Ms. Grønås was Independent Non-Executive Director at Oncoinvent ASA from 2016 to 2019 and Senior Vice President-Operations at Algeta ASA. Education includes a graduate degree from the University of Oslo.